Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea

Current Cardiology Reports

Volumn 15, Issue 8, 2013, Pages

  Pataka, Athanasia ^a   Riha, Renata L ^b  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cardiovascular disease; Cerebrovascular disease; Continuous positive airway pressure; CPAP; Heart failure; Obstructive sleep apnea; Review

Indexed keywords

CARDIOVASCULAR DISEASE; HUMAN; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP DISORDERED BREATHING; CARDIOVASCULAR DISEASES; COMPLICATION; SLEEP APNEA, OBSTRUCTIVE;

CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84880184568     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0385-z     Document Type: Article

References (84)

1. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-53. (Pubitemid 40386782)
2. Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnea in adults. Cochrane Database Syst Rev. 2006;3, CD001106.
3. Jennum P, Riha RL. Epidemiology of sleep apnea/hypoapnea syndrome and sleep-disordered breathing. Eur Respir J. 2009;33:907-14.
4. Marler M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest. 2003;124:1400-5. (Pubitemid 37290051)
5. Hu FB, Willett WC, Manson JE, Colditz GA, Rimm EB, Speizer FE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol. 2000;35:308-13. (Pubitemid 30125518)
6. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000;283:1829-36. (Pubitemid 30207619)
7. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84. (Pubitemid 30262394)
8. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19-25. (Pubitemid 32095247)
9. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735-41. (Pubitemid 38647933)
10. McNicholas WT, Bonsigore MR. Sleep apnea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms, and research priorities. Management Committee of EU COST ACTION B26. Eur Respir J. 2007;29:156-78. (Pubitemid 46092013)
11. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364-7. (Pubitemid 38993843)
12. Bradley TD, Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet. 2009;373:82-93.
13. Ferrier K, CampbellA, Yee B, RichardsM, O'Meeghan T, Weatherall M, et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest. 2005;128:2116-22. (Pubitemid 41507549)
14. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-31. (Pubitemid 46551635)
15. Naughton MT, Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med. 1998;19:99-113. (Pubitemid 28164534)
16. Koehnlein T, Welte T, Tan LB, Elliott MW. Central sleep apnea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax. 2002;57:547-54. (Pubitemid 34627989)
17. Riha RL. Clinical assessment of the obstructive sleep apnea/hypoapnea syndrome. Ther Adv Respir Dis. 2010;4:83-91.
18. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med. 2001;164:2147-65. (Pubitemid 34032928)
19. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180:692-700.
20. Yumino D, Redolfi S, Ruttanaumpawan P, SuMC, Smith S, Newton GE, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598-605.
21. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84. (Pubitemid 30262394)
22. O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179:1159-64.
23. Jones A, Vennelle M, Connell M, McKillop G, Newby DE, Douglas NJ, et al. Arterial stiffness and endothelial function in obstructive sleep, Apnea/Hypopnea Syndrome. Sleep Med. (in press).
24. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417-23. (Pubitemid 47205794)
25. Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. European Respiratory Society; EU COSTACTION B26 members. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society, and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633-46.
26. Butt M, Dwivedi G, Shantsila A, Khair OA, Lip GY. Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Circulation: Heart Failure. 2012;5:226-33.
27. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167:757-64.
28. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, Almeida-Gonzalez C. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest. 2006;129:1459-67. (Pubitemid 43894973)
29. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229-35. (Pubitemid 44914309)
30. Barbé F, Mayoralas LR, Duran J, Masa JF, Maimó A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001;134:1015-23. (Pubitemid 32488655)
31. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in non-sleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307:2161-8.
32. Arias MA, García-Río F, Alonso-Fernández A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106-13.
33. Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis. 2009;51:363.
34. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008;52:343-6. (Pubitemid 352001344)
35. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;3:19-25. (Pubitemid 32095247)
36. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Javier Nieto F, et al. Sleep disordered breathing and mortality: 18-year follow-up of the Wisconsin Sleep Cohort. Sleep. 2008;31:1071-8.
37. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J. 2006;28:596.
38. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnea with myocardial infarction in men. Lancet. 1990; 336:261.
39. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99:26-30. (Pubitemid 44969334)
40. Saletu M, Sauter C, Lalouschek W, Saletu B, Kapfhammer G, Benesch T, et al. Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea? Atherosclerosis. 2008;196:810-6.
41. Scharf SM, Bianco JA, Tow DE, Brown R. The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary a2tery disease. Circulation. 1981;63:871-5. (Pubitemid 11146902)
42. Can M, Açikgöz S, Mungan G, Bayraktaroǧlu T, Koçak E, Güven B, Demirtas S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006;129:233-7. (Pubitemid 43289839)
43. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007;176:1274.
44. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnea and nocturnal angina. Lancet. 1995;345:1085-7.
45. Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke. 2001;32:1271-8.
46. Arzt M, Yount T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447-51. (Pubitemid 43069819)
47. McArdle N, Riha RL, Vennelle M, Coleman EL, Dennis MS, Warlow CP, Douglas NJ. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case-control study in patients with transient ischemic attacks. Stroke. 2003;34:2916-21. (Pubitemid 37517769)
48. Hsu CY, Vennelle M, Li HY, Engleman HM, Dennis MS, Douglas NJ. Sleep-disordered breathing after stroke: a randomized controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatr. 2006;77:1143-9. (Pubitemid 44453248)
49. Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep. 2008;31:1207-13.
50. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, Franklin KA. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008;168:297-301. (Pubitemid 351281676)
51. Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L, Soriano Y, Román-Sánchez P, Illa FB, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea. a 5-year follow-up study. Am J Respir Crit Care Med. 2009;180:36-41.
52. Parra O, Arboix A, Montserrat JM, Quintó L, Bechich S, García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J. 2004;24:267-72. (Pubitemid 39139795)
53. Martínez-García MA, Galiano-Blancart R, Román-Sánchez P, Soler-Cataluña JJ, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest. 2005;128:2123-9. (Pubitemid 41507550)
54. Martínez-García MA, Campos-Rodríguez F, Soler-Cataluña JJ, Catalán-Serra P, Román-Sánchez P, Montserrat JM. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnea: effect of CPAP treatment. Eur Respir J. 2012;39:906-12.
55. Wessendorf TE, Wang YM, Thilmann AF, Sorgenfrei U, Konietzko N, Teschler H. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure in stroke. Eur Respir J. 2001;18:623-9. (Pubitemid 33040619)
56. Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol. 2006;13:198-200.
57. Sandberg O, Franklin KA, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnea: a randomized treatment study. Eur Respir J. 2001;18:630-4. (Pubitemid 33040620)
58. Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW. Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med. 2009;103:59-66.
59. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154-9. (Pubitemid 28262123)
60. Arzt M, Young T, Finn L, Skatrud JB, Ryan CM, Newton GE, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med. 2006;166:1716-22. (Pubitemid 44414458)
61. Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness; a randomized, controlled trial. Ann Intern Med. 2001;134:1015-23. (Pubitemid 32488655)
62. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229-35. (Pubitemid 44914309)
63. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-442.
64. Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005;294:3124-30. (Pubitemid 43016804)
65. Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary edema: a meta-analysis. Lancet. 2006;367:1155-63.
66. Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev. 2008;3, CD005351.
67. NaughtonMT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473-9.
68. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025-33. (Pubitemid 41609095)
69. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61-6. (Pubitemid 30430554)
70. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115:3173-80. (Pubitemid 47012231)
71. Arzt M, Schulz M, Schroll S, Budweiser S, Bradley TD, Riegger GA, et al. Time course of continuous positive airway pressure effects on central sleep apnea in patients with chronic heart failure. J Sleep Res. 2009;18:20-5.
72. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998;98:2269-75. (Pubitemid 28533845)
73. Khayat RN, Abraham WT, Patt B, Roy M, Hua K, Jarjoura D. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: a pilot study. Chest. 2008;134:1162.
74. Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servo-ventilation for treatment of sleepdisordered breathing in heart failure: a systematic review and metaanalysis. Chest. 2012.
75. Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, NaruiK, et al. JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail. 2010;3:140-8.
76. Otsuka K, Sadakane N, Ozawa T. Arrythmogenic properties of disordered breathing during sleep in patients with cardiovascular disorders. Clin Cardiol. 1987;10:771-82. (Pubitemid 18000915)
77. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Sleep Heart Health Study Association of nocturnal arrhythmias with sleep-disordered breathing. Am J Respir Crit Care Med. 2006;173:910-6.
78. Simantirakis EN, Schiza SI, Marketou ME, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J. 2004;25:1070-6. (Pubitemid 38869427)
79. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-94. (Pubitemid 36628941)
80. Garrigue S, Bordier P, Jais P, Shah DC, Hocini M, Raherison C, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med. 2002;346:4404-12.
81. Luthje L, Renner B, Kessels R, Vollmann D, Raupach T, Gerritse B, et al. Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnea. Eur J Heart Fail. 2009;11:273-80.
82. Pepin JL, Defaye P, Garrigue S, PoezevaraY, Levy P. Overdrive pacing does not improve obstructive sleep apnea syndrome does not improve obstructive sleep apnea syndrome. Eur Respir J. 2005;25:343-7. (Pubitemid 40246537)
83. Simantirakis EN, Schiza SE, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, Siafakas NM, et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med. 2005;353:2568-77. (Pubitemid 41785894)
84. Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C, Bozkurt B, Hirshkowitz M. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007;8:31-6. (Pubitemid 46044131)